Scimeca, Manuel http://orcid.org/0000-0003-0585-1309
Rovella, Valentina http://orcid.org/0000-0002-3311-486X
Caporali, Sabrina http://orcid.org/0000-0002-5190-0346
Shi, Yufang http://orcid.org/0000-0001-8964-319X
Bischof, Julia http://orcid.org/0000-0002-6672-6571
Woodsmith, Jonathan http://orcid.org/0000-0002-0790-3726
Tisone, Giuseppe http://orcid.org/0000-0001-8860-5909
Sica, Giuseppe http://orcid.org/0000-0002-7407-0584
Amelio, Ivano http://orcid.org/0000-0002-9126-5391
Melino, Gerry http://orcid.org/0000-0001-9428-5972
Mauriello, Alessandro http://orcid.org/0000-0002-7351-5676
Bove, Pierluigi http://orcid.org/0000-0002-4788-2982
Funding for this research was provided by:
HUB LIFE SCIENCE – Advanced Diagnostic- Italian network of excellence for advanced diagnosis (PNC-E3-2022-23683266, PNC-E3-2022-23683266, PNC-E3-2022-23683266)
Fondazione AIRC per la Ricerca sul Cancro (IG 2022 ID 27366; 2023-2027)
Article History
Received: 18 August 2023
Accepted: 16 February 2024
First Online: 21 March 2024
Declarations
:
: All the procedures carried out in the research with participation of humans were in compliance with the ethical standards of the institutional and/or national ethics committee and with the Helsinki Declaration of 1964 and its subsequent changes or with comparable ethics standards. Informed voluntary consent was obtained from every participant of the study. The research protocol has been approved by ethical committee of the “Policlinico Tor Vergata” (number#96-19).
: Not applicable.
: The authors declare no other conflict of interest.